Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2020 2
2021 1
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
First Report of OXA-181-Producing Enterobacterales Isolates in Latin America.
Cuicapuza D, Alvarado L, Tocasca N, Aguilar D, Gómez-de-la-Torre JC, Salvatierra G, Tsukayama P, Tamariz J. Cuicapuza D, et al. Microbiol Spectr. 2023 Jun 15;11(3):e0458422. doi: 10.1128/spectrum.04584-22. Epub 2023 Apr 6. Microbiol Spectr. 2023. PMID: 37022279 Free PMC article.
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection.
Hueda-Zavaleta M, Gómez de la Torre JC, Cáceres-Del Aguila JA, Muro-Rojo C, De La Cruz-Escurra N, Arenas Siles D, Minchón-Vizconde D, Copaja-Corzo C, Bardales-Silva F, Benites-Zapata VA, Rodriguez-Morales AJ. Hueda-Zavaleta M, et al. Among authors: gomez de la torre jc. Vaccines (Basel). 2022 Mar 24;10(4):502. doi: 10.3390/vaccines10040502. Vaccines (Basel). 2022. PMID: 35455251 Free PMC article.
Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine.
Gómez de la Torre JC, Hueda-Zavaleta M, Cáceres-DelAguila JA, Muro-Rojo C, Cruz-Escurra N, Benítes-Zapata VA. Gómez de la Torre JC, et al. Vaccines (Basel). 2023 Apr 25;11(5):894. doi: 10.3390/vaccines11050894. Vaccines (Basel). 2023. PMID: 37242998 Free PMC article.
Determination of PaO2/FiO2 after 24 h of invasive mechanical ventilation and ΔPaO2/FiO2 at 24 h as predictors of survival in patients diagnosed with ARDS due to COVID-19.
Hueda-Zavaleta M, Copaja-Corzo C, Miranda-Chávez B, Flores-Palacios R, Huanacuni-Ramos J, Mendoza-Laredo J, Minchón-Vizconde D, Gómez de la Torre JC, Benites-Zapata VA. Hueda-Zavaleta M, et al. PeerJ. 2022 Dec 13;10:e14290. doi: 10.7717/peerj.14290. eCollection 2022. PeerJ. 2022. PMID: 36530414 Free PMC article.
Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave in Peru.
Hueda-Zavaleta M, Gómez de la Torre JC, Cáceres-DelAguila JA, Muro-Rojo C, De La Cruz-Escurra N, Copaja-Corzo C, Aragón-Ayala CJ, Benítes-Zapata VA. Hueda-Zavaleta M, et al. Among authors: gomez de la torre jc. Vaccines (Basel). 2023 Feb 15;11(2):447. doi: 10.3390/vaccines11020447. Vaccines (Basel). 2023. PMID: 36851324 Free PMC article.
Cerebral Cryptococcosis Associated with CD4+ T-lymphocytopenia in Non-HIV Patients after SARS-CoV-2 Infection: Case Series in a Specialized Institute in Lima, Peru.
Huamani-Córdova JM, Hueda-Zavaleta M, Vargas-Bellina V, Simbron-Ribbeck L, Chong-Chinchay KDR, Gómez de la Torre JC, Benítes-Zapata VA. Huamani-Córdova JM, et al. Trop Med Infect Dis. 2023 Mar 22;8(3):182. doi: 10.3390/tropicalmed8030182. Trop Med Infect Dis. 2023. PMID: 36977183 Free PMC article.
13 results